The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
you've got this synthetic pathway you have at first glance you have two things that are similar a statin which inhibits one enzyme in the pathway this other drug that inhibits another enzyme in the pathway and yet one seems to be okay and one seems to know there's several other cholesterol sync squalling synthesis inhibitors that have failed for one reason or another
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.